Download original image
Fig. 2.
linical outcomes of patients with any
KRAS, NRAS
, and/or
BRAF
mutation [RAS/RAF(+)] or without mutations [RAS/RAF(-)]
(A, B)
. Comparison between subgroups;
BRAF
V600E (+) vs.
BRAF
V600E (-)
(C)
and RAS (+) vs. RAS (-)
(D)
.
Blood Res 2020;55:159~168
https://doi.org/10.5045/br.2020.2020137
© Blood Research
© 2024. BLOOD RESEARCH All rights reserved. Powered by
INFOrang Co., Ltd